Effect of VEGF receptor inhibitor PTK787/ZK222548 combined with ionizing radiation on endothelial cells and tumour growth

The vascular endothelial growth factor (VEGF) receptor is a major target for anti-angiogenesis-based cancer treatment. Here we report the treatment effect of ionizing radiation in combination with the novel orally bioavailable VEGF receptor tyrosine kinase inhibitor PTK787/ZK222584 on endothelial ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Hess, C, Vuong, V, Hegyi, I, Riesterer, O, Wood, J, Fabbro, D, Glanzmann, C, Bodis, S, Pruschy, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364010/
https://www.ncbi.nlm.nih.gov/pubmed/11747347
http://dx.doi.org/10.1054/bjoc.2001.2166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364010/
https://www.ncbi.nlm.nih.gov/pubmed/11747347
http://dx.doi.org/10.1054/bjoc.2001.2166

Ejemplares similares